SHA:600521 Market Cap

SHA:600521 has a market cap or net worth of 22.8 billion as of March 20, 2026. Its market cap has increased by 3.58% in one year.

Market Cap

22.80B

Enterprise Value

29.08B

Revenue

8.71B

Ranking

n/a

PE Ratio

47.94

Stock Price

15.30

Market Cap Chart

Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 22.80B, an increase of 474.20%. That is a compound annual growth rate of 7.87%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	22.80B	-9.84%
Dec 31, 2025	25.29B	-2.34%
Dec 31, 2024	25.89B	19.93%
Dec 29, 2023	21.59B	-33.42%
Dec 30, 2022	32.43B	0.57%
Dec 31, 2021	32.25B	-34.43%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kangmei Pharmaceutical	25.86B
Hubei Jumpcan Pharmaceutical	25.32B
Chengdu Kanghong Pharmaceutical Group	25.12B
Dizal (Jiangsu) Pharmaceutical	23.57B
Jiangsu Nhwa Pharmaceutical Co., LTD	22.99B
Jilin Aodong Pharmaceutical Group	21.78B
Tasly Pharmaceutical Group	21.29B
Apeloa Pharmaceutical Co.,Ltd	21.00B

Market Cap Rankings